Patients | All IM | PM | DM | IBM | 2nd IM | no-IM |
---|---|---|---|---|---|---|
Number | 19 | 10 | 7 | 2 | 5 | 2 |
Gender (M/F) | 3/16 | 0/10 | 1/6 | 2/0 | 0/5 | 1/1 |
Age (years) mean ± SD | 53.2±17 | 51.6±20.1 | 53.2±15.6 | 61±2.8 | 51.2±11.8 | 55±1.4 |
Age at onset (years) mean ± SD | 49.5±17.6 | 47.7±20.2 | 50.5±17.3 | 55±1.4 | 44.4±6.2 | 52±2.8 |
CX3CL1 (ng/ml) mean ± SD | 1.29±0.9 | 1.14±0.83 | 1.65±0.97 | 0.79±0.25 | 1.5±0.68 | 0.58±0.07 |
CKs (U/L) mean ± SD | 2512.4±3559.6 | 2927.5±3281.9 | 2456.1±4509.4 | 634.5±576.2 | 1489.2±934,08 | 460±84.5 |
ANA (%) | 10 (52.6) | 6 (60) | 4 (57.1) | 0 | 5 (100) | 0 |
Anti-ENA (%) | 4 (21.05) | 3 (30) | 1 (14.2) | 0 | 4 (80) | 0 |
Anti-Jo1 (%) | 3 (15.7) | 2 (20) | 1 (14.2) | 0 | 1 (20) | 0 |